Daniel Ontaneda: 1 book

The arena of multiple sclerosis (MS) treatment has changed substantially over the past 20 years. Now nine different agents are approved for use in MS with several different routes of administration, safety characteristics and efficacy profiles. For the clinician and patient the availability of agents...